Since 2011, MMM has been part of several EU research projects.
MMM is part of SPIOMET4HEALTH, a new Horizon 2020 health project whose main objective is to study, in a multi-centric phase II clinical trial, a new treatment for Polycystic Ovary Syndrome (PCOS), the most common endocrine-metabolic disorder among women of reproductive age, a disorder affecting 5-10% of women worldwide.
This syndrome is the most frequent cause of infertility, and is also associated with other lifelong disorders, like type 2 diabetes, premenopausal cancer and anxiety/depression, with a negative impact on the (mental) health and quality of life of these women and their children.
To face this challenge, SPIOMET4HEALTH, coordinated by Fundació Sant Joan de Déu/Hospital Sant Joan de Déu, will collaborate with 17 organizations: key research groups working on PCOS across Europe.
The design of SPIOMET4HEALTH foresees that the patients (adolescents and young adults) will be engaged over the entire timespan of the project and will also contribute to the ultimate study evaluation.
MMM will support the engagement of patients in the project and will map policies that are relevant for patients suffering from PCOS, raising awareness of policymakers and the public on this disorder.
The delegation has been chosen to participate in the EU research project CIRC4Life funded by the Horizon 2020 Programme. We are in charge of the communications and conducting 4 consumer surveys on attitudes to recycling and reuse, the eco-points system (rewarding system to encourage recycling and sustainable consumption) and the new developed products.
Make Mothers Matter is part of the new EU research network on Peripartum Depression Disorder (PPD) where we are co-leading a working group on the dissemination of results.
The main goal of Riseup-PPD COST ACTION which started in April 2019 and will have a duration of 5 years, is to establish a Pan-European multidisciplinary network of researchers dedicated to the understanding of PPD, from its prevention and assessment to its treatment and global impact. Currently, 27 countries in the EU and beyond are part of this network including Albania, Israel, Turkey, Serbia, Bosnia, Norway, US and Brazil.
Riseup-PPD aims at filling gaps in PPD research, practice and social awareness by developing updated reviews, fostering research efforts on the standardisation of diagnostic criteria, the development of adequate screening tools and cost-effectiveness evaluation of prevention and treatment programs.
Finally, Riseup-PPD aims at developing a clinical protocol at EU level on how to treat PPD.
MMM is part of a new Pan-European Family Support Network. The main aim and objective of the Action is to build collaborative pathways between researchers, practitioners, policy-makers, children, families, public and private agencies and society in general. This will create the necessary framework to inform on family policies and practices, with the underlying goal of ensuring children’s rights and families’ well-being.
The project covers 35 European countries in the EU and beyond. It started in March 2019 and will have a duration of 4 years until March 2023.
The European Family Network aims to contribute to high quality training of future generations of European researchers in the field of family support, with an evidence-based and pluralistic approach.
The Family Platform
The Social Platform, of which Make Mothers Matter is a member, recently held its annual Flagship Conference "Building Social Europe". This was an official side event of the Portuguese Presidency of the Council
Our campaign, aimed at supporting Afghan women’s pressing request to a continued right to education, passed two important milestones at the European Parliament recently.
Make Mothers Matter welcomes the newly adopted Council Recommendation establishing a European Child Guarantee that aims at reducing the number of children at risk of poverty and social exclusion within the Unio
The resulting Public Consultation initiative aims at gathering feedback from stakeholders on the challenges and opportunities of demographic ageing, taking a life-cycle approach based on intergenerational solid